Drug Information

Drug General Information
Drug ID
D0FL7O
Former ID
DNC012639
Drug Name
4-Biphenyl-4-yl-2-(1-pentyl-hexyl)-1H-imidazole
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527102]
Structure
Download
2D MOL

3D MOL
Formula
C26H34N2
Canonical SMILES
CCCCCC(CCCCC)C1=NC=C(N1)C2=CC=C(C=C2)C3=CC=CC=C3
InChI
1S/C26H34N2/c1-3-5-8-14-24(15-9-6-4-2)26-27-20-25(28-26)23-18-16-22(17-19-23)21-12-10-7-11-13-21/h7,10-13,16-20,24H,3-6,8-9,14-15H2,1-2H3,(H,27,28)
InChIKey
FAJKZAIMTCYING-UHFFFAOYSA-N
PubChem Compound ID
10109974
Target and Pathway
Target(s) Sodium channel Target Info Inhibitor [527102]
Voltage-gated sodium channel subunit alpha Nav1.3 Target Info Inhibitor [527102]
KEGG Pathway Dopaminergic synapse
Reactome Interaction between L1 and AnkyrinsR-HSA-445095:Interaction between L1 and Ankyrins
References
Ref 527102Bioorg Med Chem Lett. 2004 Jul 5;14(13):3521-3.2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators.
Ref 527102Bioorg Med Chem Lett. 2004 Jul 5;14(13):3521-3.2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.